» Articles » PMID: 8643571

Adenine Phosphoribosyltransferase-deficient Mice Develop 2,8-dihydroxyadenine Nephrolithiasis

Overview
Specialty Science
Date 1996 May 28
PMID 8643571
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Adenine phosphoribosyltransferase (APRT) deficiency in humans is an autosomal recessive syndrome characterized by the urinary excretion of adenine and the highly insoluble compound 2,8-dihydroxyadenine (DHA) that can produce kidney stones or renal failure. Targeted homologous recombination in embryonic stem cells was used to produce mice that lack APRT. Mice homozygous for a null Aprt allele excrete adenine and DHA crystals in the urine. Renal histopathology showed extensive tubular dilation, inflammation, necrosis, and fibrosis that varied in severity between different mouse backgrounds. Thus, biochemical and histological changes in these mice mimic the human disease and provide a suitable model of human hereditary nephrolithiasis.

Citing Articles

Adenine phosphoribosyltransferase (APRT) deficiency: an increasingly recognized disease.

Leow E, Ganesan I, Chong S, Yap C, Chao S, Wang F Int Urol Nephrol. 2025; .

PMID: 39982660 DOI: 10.1007/s11255-025-04420-6.


Lack of accelerated ovarian aging in a follicle-stimulating hormone receptor haploinsufficiency model.

Mehalko K, Kim M, Paye S, Koh K, Lu R, Benayoun B Transl Med Aging. 2023; 7:1-8.

PMID: 36714222 PMC: 9878709. DOI: 10.1016/j.tma.2023.01.001.


The Role of Mitochondrial and Redox Alterations in the Skeletal Myopathy Associated with Chronic Kidney Disease.

Thome T, Kim K, Dong G, Ryan T Antioxid Redox Signal. 2022; 38(4-6):318-337.

PMID: 36245209 PMC: 9986033. DOI: 10.1089/ars.2022.0143.


Integrative phosphatidylcholine metabolism through phospholipase A in rats with chronic kidney disease.

Wang Y, Zhang Z, Liu H, Guo Z, Zou L, Zhang Y Acta Pharmacol Sin. 2022; 44(2):393-405.

PMID: 35922553 PMC: 9889763. DOI: 10.1038/s41401-022-00947-x.


Treatment of Chronic Kidney Disease with Extracellular Vesicles from Mesenchymal Stem Cells and CD133 Expanded Cells: A Comparative Preclinical Analysis.

Miyasaki D, Senegaglia A, Moura S, Leitolis A, Capriglione L, Fracaro L Int J Mol Sci. 2022; 23(5).

PMID: 35269664 PMC: 8910174. DOI: 10.3390/ijms23052521.


References
1.
Lee P . Developmental changes of adenosine deaminase, xanthine oxidase, and uricase in mouse tissues. Dev Biol. 1973; 31(2):227-33. DOI: 10.1016/0012-1606(73)90259-5. View

2.
Sahota A, Chen J, Behzadian M, Ravindra R, Takeuchi H, Stambrook P . 2,8-Dihydroxyadenine lithiasis in a Japanese patient heterozygous at the adenine phosphoribosyltransferase locus. Am J Hum Genet. 1991; 48(5):983-9. PMC: 1683049. View

3.
Moore G, Ledford M . A modified fluorometric assay for adenine in plasma and urine. Biochem Med. 1975; 14(2):147-51. DOI: 10.1016/0006-2944(75)90030-7. View

4.
Van Acker K, Simmonds H, Potter C, Cameron J . Complete deficiency of adenine phosphoribosyltransferase. Report of a family. N Engl J Med. 1977; 297(3):127-32. DOI: 10.1056/NEJM197707212970302. View

5.
BARTLETT G . Metabolism by the rabbit of intravenously administered adenine. Transfusion. 1977; 17(4):351-7. DOI: 10.1046/j.1537-2995.1977.17477216863.x. View